Trade Summary

4 days ago, Saxonov Serge, serving as Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 30,000 shares at $34.44 per share, for a total transaction value of $1,033,268.62. Following this transaction, Saxonov Serge now holds 1,108,380 shares of TXG.

This sale represents a 2.64% decrease in Saxonov Serge's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:22 PM ET, 2 days after the trade was made.

10x Genomics, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.